These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6497402)

  • 1. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Fujita K; Murayama T; Sayama T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of etoposide for urogenital tumors].
    Kinjo T; Murase T; Aota Y; Shimoji T; Mitsuya H
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1267-71. PubMed ID: 4004290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A phase II study of NK171 (etoposide)].
    Kimura K; Niitani H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial infusion of antineoplastic agents in the treatment of urogenital cancer].
    Uyam T; Moriwaki S
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):415-20. PubMed ID: 7184407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral VP-16-213 in transitional cell carcinoma of the bladder: a phase II study.
    Panduro J; Hansen M; Hansen HH
    Cancer Treat Rep; 1981; 65(7-8):703-4. PubMed ID: 7248987
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
    Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.
    Scagliotti G; Lodico D; Gozzelino F; Pescetti G
    Chemioterapia; 1984 Oct; 3(5):324-6. PubMed ID: 6532545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.
    Eagan RT; Ingle JN; Creagan ET; Frytak S; Kvols LK; Rubin J; McMachon RT
    Cancer Treat Rep; 1978 May; 62(5):843-4. PubMed ID: 657168
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Hashimoto H; Tokumitsu M; Morikawa M; Numata A; Yachiku S; Iuchi H; Yamauchi K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
    Ponder BA; Oliver RT
    Cancer Chemother Pharmacol; 1984; 12(1):64-5. PubMed ID: 6690078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase I clinical study of NK 171 (etoposide)].
    Kimura K; Yamada K; Niitani H
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):851-6. PubMed ID: 2985006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
    Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of etoposide therapy in urogenital cancer].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1929-35. PubMed ID: 8978800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
    Jungi WF; Senn HJ; Beckmann C; Flury R; Frei P; Holdener E
    Schweiz Med Wochenschr; 1975 Oct; 105(42):1365-9. PubMed ID: 179137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostate.
    Nevin JE; Melnick I; Baggerly JT; Landes R; Easley CA
    Va Med Mon (1918); 1975 Aug; 102(8):614-20. PubMed ID: 1163099
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].
    Joss R; Goldhirsch A; Cavalli F; Weber W; Kaplan S; Obrecht JP; Sonntag R; Brunner KW
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1331-4. PubMed ID: 7197802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide infusions for treatment of metastatic lung cancer.
    Steward WP; Thatcher N; Edmundson JM; Shiu W; Wilkinson PM
    Cancer Treat Rep; 1984 Jun; 68(6):897-9. PubMed ID: 6329509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.